Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02519452 |
|---|---|
| Brief Title: | A Study of Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma |
| First Submitted : | August 6, 2015 |
| First Submitted that Met QC Criteria : | August 6, 2015 |
| First Posted : | August 11, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | December 3, 2020 |
| Last Update Posted : | December 4, 2020 |